PMVP PMV Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$1,79
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,0252 haftanın en düşüğü
$1,9152 haftanın en yükseği
Piyasa Değeri (MRQ)
$96M
P/E
-1.2
Hisse Başına Kâr
$-1.48
rozetleriniz
52 Haftlık Aralık
$1–$2
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$4
P/E
-1.2
ROE
-63.4%
Net Kâr Marjı
-1226.8%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
PMVP Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.79
Piyasa Değeri (MRQ)
$96M
P/E
-1.2
Hisse Başına Kâr
$-1.48
ROE
-63.4%
52 Haftlık Aralık
$1–$2
PMVP Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-1.482020-12-31 → 2025-12-31
Serbest Nakit Akışı$-74M2020-12-31 → 2025-12-31
Net kar marjı-1226.8%2020-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PMVP | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -1.25Y ort. ≈-5.6 | ≈-5.6 | · | · | |
| P/S (F/S) | 15.15Y ort. ≈495.9 | ≈495.9 | 73.7 | Düşük değerli | |
| F/D (MRQ) | 1.35Y ort. ≈1.4 | ≈1.4 | 2.5 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -1.35Y ort. ≈-6.5 | ≈-6.5 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -1.35Y ort. ≈-6.8 | ≈-6.8 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.95Y ort. ≈1.4 | ≈1.4 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | PMVP | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Operating Margin (Faaliyet Kâr Marjı) | -1360.4%5Y ort. ≈-3597.3% | ≈-3597.3% | -3199.0% | En üst düzey | |
| EBITDA Margin (FAVÖK Marjı) | -1360.4%5Y ort. ≈-3597.3% | ≈-3597.3% | -3199.0% | En üst düzey | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -1261.1%5Y ort. ≈-3496.1% | ≈-3496.1% | -2294.8% | Aynı seviyede | |
| Net Profit Margin (Net Kâr Marjı) | -1226.8%5Y ort. ≈-3460.0% | ≈-3460.0% | -2452.9% | Aynı seviyede | |
| ROA | -50.5%5Y ort. ≈-28.9% | ≈-28.9% | -57.6% | Aynı seviyede | |
| ROE | -63.4%5Y ort. ≈-34.3% | ≈-34.3% | -63.4% | Aynı seviyede | |
| ROIC | -80.1%5Y ort. ≈-40.8% | ≈-40.8% | -68.6% | Ortalamanın altında |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PMVP | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 7.75Y ort. ≈16.9 | ≈16.9 | 7.7 | Aynı seviyede | |
| Quick Ratio (Cari Oran) | 9.95Y ort. ≈16.5 | ≈16.5 | 7.5 | Aynı seviyede |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | PMVP | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -40.5%5Y ort. ≈167.9% | ≈167.9% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 20.4%5Y ort. ≈121.9% | ≈121.9% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 57.6% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | PMVP | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.0 | ≈0.0 | 0.0 | En üst düzey |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
9.8%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 14, 2026 | $-0.34 | $-0.40 | 14.0% |
| 31 Mart 2026 | May 8, 2026 | $-0.34 | $-0.42 | 18.7% |
| 31 Aralık 2025 | $-0.34 | $-0.41 | 17.7% | |
| 30 Eylül 2025 | $-0.40 | $-0.41 | 2.6% | |
| 30 Haziran 2025 | $-0.41 | $-0.39 | -4.9% | |
| 31 Mart 2025 | $-0.34 | $-0.38 | 11.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $70M | $59M | $56M | $52M | $36M | $24M | $21M | |
| SG&A Expense | $16M | $27M | $24M | $25M | $22M | $11M | $6M | |
| Operating Expenses | $86M | $85M | $80M | $77M | $58M | $35M | $27M | |
| Operating Income | $-86M | $-85M | $-80M | $-77M | $-58M | $-35M | $-27M | |
| Other Non-op | $6M | $11M | $11M | $4M | $470.0K | $508.0K | $1M | |
| Pretax Income | $-80M | $-75M | $-69M | $-73M | $-58M | $-34M | $-25M | |
| Income Tax | $-2M | $-16M | $2.0K | $-9.0K | $23.0K | $6.0K | $8.0K | |
| Net Income | $-78M | $-59M | $-69M | $-73M | $-58M | $-34M | $-25M | |
| EPS (Basic) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 | $-2.40 | · | |
| EPS (Diluted) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 | $-2.40 | · | |
| Shares (Basic) | 52,541,613 | 51,578,807 | 48,014,645 | 45,594,824 | 45,137,656 | 14,364,475 | · | |
| Shares (Diluted) | 52,541,613 | 51,578,807 | 48,014,645 | 45,594,824 | 45,137,656 | 14,364,475 | · | |
| EBITDA | $-86M | $-85M | $-80M | $-77M | $-58M | $-35M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $41M | $38M | $108M | $172M | $361M | $73M | |
| Short-term Investments | $75M | $129M | $165M | $133M | $125M | · | · | |
| Prepaid Expense | $2M | $6M | $4M | $5M | $3M | $3M | $607.0K | |
| Current Assets | $115M | $176M | $207M | $247M | $301M | $365M | $102M | |
| PP&E (Net) | $237.0K | $409.0K | $11M | $11M | $3M | $569.0K | $739.0K | |
| PP&E (Gross) | $2M | $2M | $14M | $13M | $5M | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | $3M | $2M | $2M | $2M | $1M | |
| Other Non-current Assets | $297.0K | $235.0K | $190.0K | $313.0K | $221.0K | $201.0K | $201.0K | |
| Total Assets | $117M | $191M | $252M | $270M | $332M | $366M | $103M | |
| Accounts Payable | $3M | $7M | $3M | $3M | $3M | $2M | $3M | |
| Accrued Liabilities | $8M | $7M | $10M | $7M | $9M | $5M | $2M | |
| Current Liabilities | $11M | $14M | $14M | $11M | $12M | $6M | $5M | |
| Capital Leases | $435.0K | $838.0K | $12M | $13M | $11M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $51.0K | |
| Total Liabilities | $12M | $15M | $26M | $24M | $23M | $6M | $5M | |
| Retained Earnings | $-446M | $-369M | $-310M | $-241M | $-168M | $-110M | $-75M | |
| AOCI | $84.0K | $139.0K | $224.0K | $-445.0K | $-78.0K | · | $-3.0K | |
| Stockholders' Equity | $105M | $176M | $226M | $246M | $309M | $359M | $-70M | |
| Liabilities + Equity | $117M | $191M | $252M | $270M | $332M | $366M | $103M | |
| Shares Outstanding | 53,331,766 | 51,935,134 | 51,445,862 | 45,771,332 | 45,433,684 | 44,777,818 | 3,046,200 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $9M | $12M | $10M | $5M | $2M | $908.0K | |
| Operating Cash Flow | $-74M | $-51M | $-56M | $-64M | $-47M | $-33M | $-22M | |
| CapEx | $29.0K | $655.0K | $962.0K | $8M | $1M | $148.0K | $109.0K | |
| Investing Cash Flow | $70M | $53M | $-51M | $-1M | $-144M | $28M | $3M | |
| Stock Issued | · | · | $35M | · | · | $223M | · | |
| Net Stock Activity | · | · | $35M | · | · | $223M | · | |
| Financing Cash Flow | $505.0K | $313.0K | $36M | $958.0K | $2M | $293M | $62M | |
| Net Change in Cash | $-3M | $2M | $-71M | $-64M | $-188M | $288M | $43M | |
| Taxes Paid | · | · | · | · | $23.0K | $6.0K | $8.0K | |
| Free Cash Flow | $-74M | $-52M | $-57M | $-72M | $-48M | $-33M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1360.4% | -802.0% | -717.3% | -2124.1% | -12982.8% | -5367.4% | · | |
| Net Margin | -1226.8% | -551.0% | -617.3% | -2021.4% | -12883.3% | -5290.3% | · | |
| Pretax Margin | -1261.1% | -702.1% | -617.3% | -2021.7% | -12878.2% | -5289.4% | · | |
| EBITDA Margin | -1360.4% | -802.0% | -717.3% | -2124.1% | -12982.8% | -5367.4% | · | |
| ROA | -50.5% | -26.5% | -26.4% | -24.4% | -16.6% | -14.7% | · | |
| ROE | -63.4% | -31.4% | -29.8% | -28.9% | -18.3% | -9.5% | · | |
| ROIC | -80.1% | -38.1% | -35.5% | -31.3% | -18.9% | -9.7% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.1 | 12.2 | 14.8 | 22.8 | 24.7 | 56.9 | · | |
| Quick Ratio | 9.9 | 11.8 | 14.5 | 22.3 | 24.3 | 56.4 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.96 | $3.39 | $4.39 | $5.38 | $6.79 | $8.02 | · | |
| Revenue / Share | $0.12 | $0.21 | $0.23 | $0.08 | · | · | · | |
| Cash Flow / Share | $-1.40 | $-0.99 | $-1.16 | $-1.40 | · | · | · | |
| Cash / Share | $0.71 | $0.79 | $0.73 | $2.37 | $3.80 | $8.07 | · | |
| EPS (TTM) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 | $-2.40 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -40.5% | -4.6% | 208.0% | 707.8% | -31.0% | · | · | |
| Revenue CAGR 3Y | 20.4% | 187.4% | 157.9% | · | · | · | · | |
| Revenue CAGR 5Y | 57.6% | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $11M | $11M | $4M | $449.0K | $651.0K | · | |
| Net Income TTM | $-78M | $-59M | $-69M | $-73M | $-58M | $-34M | · | |
| Market Cap | $67M | $78M | $159M | $398M | $1.05B | $2.75B | · | |
| P/E | -0.8 | -1.3 | -2.2 | -5.4 | -18.0 | -25.6 | · | |
| P/S | 10.5 | 7.4 | 14.3 | 109.8 | 2337.5 | 4230.9 | · | |
| P/B | 0.6 | 0.4 | 0.7 | 1.6 | 3.4 | 7.7 | · | |
| P / Tangible Book | 0.6 | 0.4 | 0.7 | 1.6 | 3.4 | 7.7 | · | |
| P / Cash Flow | -0.9 | -1.5 | -2.9 | -6.2 | -22.5 | -84.1 | · | |
| P / FCF | -0.9 | -1.5 | -2.8 | -5.6 | -21.9 | -83.7 | · | |
| Earnings Yield | -118.4% | -75.5% | -46.5% | -18.5% | -5.5% | -3.9% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $15M | $16M | $18M | $18M | $17M | $14M | $17M | $15M | $13M | $14M | $14M | $15M | $14M | $11M | $12M | |
| SG&A Expense | $4M | $4M | $3M | $4M | $4M | $4M | $11M | $5M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $7M | |
| Operating Expenses | $19M | $19M | $19M | $23M | $23M | $22M | $25M | $22M | $20M | $18M | $20M | $20M | $21M | $19M | $18M | $19M | |
| Operating Income | $-19M | $-19M | $-19M | $-23M | $-23M | $-22M | $-25M | $-22M | $-20M | $-18M | $-20M | $-20M | $-21M | $-19M | $-18M | $-19M | |
| Other Non-op | $798.0K | $981.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $1M | $573.0K | $188.0K | |
| Pretax Income | $-18M | $-18M | $-18M | $-21M | $-21M | $-20M | $-23M | $-19M | $-17M | $-15M | $-17M | $-17M | $-19M | $-18M | $-17M | $-18M | |
| Income Tax | $3.0K | · | $26.0K | $-6.0K | $5.0K | $-2M | $0 | $74.0K | $-16M | · | $-1.0K | $4.0K | · | $-9.0K | $-2.0K | $2.0K | |
| Net Income | $-18M | $-18M | $-18M | $-21M | $-21M | $-17M | $-23M | $-19M | $-1M | $-15M | $-17M | $-17M | $-19M | $-18M | $-17M | $-18M | |
| EPS (Basic) | $-0.34 | $-0.34 | $-0.33 | $-0.40 | $-0.41 | $-0.34 | $-0.45 | $-0.37 | $-0.02 | $-0.30 | $-0.34 | $-0.38 | $-0.42 | $-0.40 | $-0.38 | $-0.41 | |
| EPS (Diluted) | $-0.34 | $-0.34 | $-0.33 | $-0.40 | $-0.41 | $-0.34 | $-0.45 | $-0.37 | $-0.02 | $-0.30 | $-0.34 | $-0.38 | $-0.42 | $-0.40 | $-0.38 | $-0.41 | |
| Shares (Basic) | 53,386,909 | 53,331,766 | · | 52,993,238 | 52,010,827 | 51,952,062 | · | 51,574,027 | 51,478,751 | 51,445,862 | 49,047,296 | 45,813,132 | 45,773,357 | 45,622,957 | 45,571,067 | 45,466,044 | |
| Shares (Diluted) | 53,386,909 | 53,331,766 | · | 52,993,238 | 52,010,827 | 51,952,062 | · | 51,574,027 | 51,478,751 | 51,445,862 | 49,047,296 | 45,813,132 | 45,773,357 | 45,622,957 | 45,571,067 | 45,466,044 | |
| EBITDA | $-19M | $-19M | · | $-23M | $-23M | $-22M | · | $-22M | $-20M | $-18M | $-20M | $-20M | $-21M | $-19M | $-18M | $-19M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $39M | $38M | $36M | $44M | $51M | $41M | $49M | $49M | $48M | $52M | $68M | $143M | $100M | $87M | $116M | |
| Short-term Investments | $67M | $54M | $75M | $93M | $98M | $109M | $129M | $134M | $164M | $150M | $150M | $119M | $86M | $159M | $190M | $167M | |
| Prepaid Expense | $2M | $2M | $2M | $3M | $3M | $3M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | $5M | $4M | $4M | |
| Current Assets | $81M | $96M | $115M | $132M | $145M | $163M | $176M | $190M | $219M | $202M | $205M | $190M | $233M | $265M | $282M | $288M | |
| PP&E (Net) | $154.0K | $203.0K | $237.0K | $255.0K | $287.0K | $376.0K | $409.0K | $10M | $11M | $11M | $11M | $11M | $11M | $10M | $9M | $5M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $14M | $15M | $15M | $14M | $14M | $14M | $12M | $11M | $7M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $296.0K | $296.0K | $297.0K | $249.0K | $248.0K | $237.0K | $235.0K | $242.0K | $182.0K | $182.0K | $180.0K | $181.0K | $314.0K | $307.0K | $308.0K | $221.0K | |
| Total Assets | $82M | $97M | $117M | $134M | $153M | $171M | $191M | $223M | $238M | $237M | $261M | $242M | $254M | $285M | $301M | $315M | |
| Accounts Payable | $2M | $2M | $3M | $3M | $3M | $4M | $7M | $2M | $5M | $859.0K | $2M | $3M | $2M | $5M | $3M | $5M | |
| Accrued Liabilities | $8M | $7M | $8M | $9M | $9M | $6M | $7M | $10M | $6M | $10M | $9M | $8M | $9M | $6M | $8M | $7M | |
| Current Liabilities | $11M | $9M | $11M | $12M | $12M | $10M | $14M | $14M | $11M | $12M | $11M | $11M | $11M | $12M | $11M | $12M | |
| Capital Leases | $0 | $0 | $435.0K | $541.0K | $643.0K | $742.0K | $838.0K | $12M | $12M | $12M | $13M | $13M | $13M | $12M | $12M | $11M | |
| Total Liabilities | $11M | $9M | $12M | $13M | $12M | $11M | $15M | $26M | $23M | $24M | $23M | $24M | $24M | $24M | $24M | $23M | |
| Retained Earnings | $-483M | $-464M | $-446M | $-428M | $-407M | $-386M | $-369M | $-346M | $-326M | $-325M | $-294M | $-278M | $-260M | $-222M | $-203M | $-186M | |
| AOCI | $-82.0K | $-15.0K | $84.0K | $91.0K | $21.0K | $84.0K | $139.0K | $410.0K | $-185.0K | $-129.0K | $-355.0K | $-328.0K | $-116.0K | $-1M | $-1M | $-666.0K | |
| Stockholders' Equity | $72M | $88M | $105M | $121M | $141M | $160M | $176M | $198M | $214M | $213M | $238M | $218M | $230M | $261M | $277M | $292M | |
| Liabilities + Equity | $82M | $97M | $117M | $134M | $153M | $171M | $191M | $223M | $238M | $237M | $261M | $242M | $254M | $285M | $301M | $315M | |
| Shares Outstanding | 53,460,432 | 53,331,766 | 53,331,766 | 52,993,238 | 52,993,238 | 51,954,135 | 51,935,134 | 51,749,504 | 51,522,125 | 51,445,862 | 51,157,636 | 46,143,536 | 45,774,761 | 45,624,860 | 45,622,610 | 45,532,392 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | |
| Operating Cash Flow | $-15M | $-20M | $-17M | $-20M | $-18M | $-18M | $-17M | $-17M | $-2M | $-16M | $-16M | $-13M | $-15M | $-17M | $-14M | $-18M | |
| CapEx | $0 | $0 | $15.0K | $-1.0K | $11.0K | $4.0K | $56.0K | $1.0K | $4.0K | $594.0K | $44.0K | $565.0K | $156.0K | $2M | $4M | $796.0K | |
| Investing Cash Flow | $-12M | $21M | $18M | $12M | $11M | $29M | $8M | $17M | $2M | $26M | $-34M | $-64M | $50M | $30M | $-15M | $-39M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $33M | · | · | · | · | · | |
| Financing Cash Flow | $143.0K | $0 | $392.0K | $0 | $103.0K | $10.0K | $172.0K | $0 | $141.0K | $0 | $33M | $2M | $12.0K | $6.0K | $276.0K | $128.0K | |
| Net Change in Cash | $-27M | $1M | $2M | $-8M | $-7M | $10M | $-9M | $284.0K | $872.0K | $10M | $-16M | $-75M | $35M | $13M | $-29M | $-57M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| Free Cash Flow | · | $-20M | · | · | · | $-18M | · | · | · | $-17M | · | · | $-15M | · | · | $-19M |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2396.1% | -1940.7% | · | -1521.8% | -1353.8% | -1114.4% | · | -837.0% | -720.1% | -617.2% | -657.8% | -746.4% | -923.9% | -1723.8% | -2961.1% | -8130.6% | |
| Net Margin | -2295.2% | -1840.6% | · | -1422.9% | -1255.0% | -901.1% | · | -735.2% | -43.3% | -517.3% | -557.6% | -646.7% | -822.7% | -1621.8% | -2865.9% | -8049.3% | |
| Pretax Margin | -2294.8% | -1840.6% | · | -1423.3% | -1254.7% | -1014.6% | · | -732.4% | -620.7% | -517.3% | -557.6% | -646.6% | -822.7% | -1622.6% | -2866.2% | -8048.5% | |
| EBITDA Margin | -2396.1% | -1940.7% | · | -1521.8% | -1353.8% | -1114.4% | · | -837.0% | -720.1% | -617.2% | -657.8% | -746.4% | -923.9% | -1723.8% | -2961.1% | -8130.6% | |
| ROA | -15.4% | -13.5% | · | -11.8% | -10.9% | -8.6% | · | -7.9% | -0.51% | -5.5% | -6.5% | -6.4% | · | -5.8% | -5.3% | -5.5% | |
| ROE | -17.1% | -14.5% | · | -13.2% | -11.9% | -9.3% | · | -8.8% | -0.56% | -6.0% | -7.1% | -7.0% | · | -6.2% | -5.6% | -5.8% | |
| ROIC | -26.4% | · | · | -18.6% | -16.3% | -12.0% | · | -11.1% | -0.66% | · | · | -9.2% | · | -7.4% | -6.5% | -6.4% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.7 | 11.1 | · | 10.8 | 12.5 | 16.8 | · | 14.0 | 19.2 | 16.8 | 19.2 | 16.6 | · | 22.8 | 24.8 | 24.7 | |
| Quick Ratio | 7.5 | 10.9 | · | 10.5 | 12.3 | 16.4 | · | 13.5 | 18.7 | 16.4 | 18.8 | 16.3 | · | 22.2 | 24.4 | 24.2 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.34 | $1.65 | · | $2.28 | $2.65 | $3.08 | · | $3.82 | $4.16 | $4.13 | $4.64 | $4.72 | · | $5.72 | $6.07 | $6.41 | |
| Revenue / Share | $0.01 | $0.02 | · | $0.03 | $0.03 | $0.04 | · | $0.05 | $0.05 | $0.06 | $0.06 | $0.06 | $0.05 | $0.02 | · | · | |
| Cash Flow / Share | · | $-0.37 | · | · | · | $-0.35 | · | · | · | $-0.31 | · | · | $-0.33 | · | · | · | |
| Cash / Share | $0.23 | $0.73 | · | $0.69 | $0.83 | $0.99 | · | $0.94 | $0.94 | $0.93 | $1.02 | $1.48 | · | $2.19 | $1.91 | $2.54 | |
| EPS (TTM) | $-1.41 | $-1.48 | · | $-1.60 | $-1.57 | $-1.18 | · | $-0.99 | $-0.96 | $-1.32 | $-1.56 | $-1.62 | $-1.62 | $-1.59 | $-1.52 | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $5M | · | $7M | $9M | $10M | · | $12M | $12M | $12M | $10M | $8M | $6M | $2M | $1M | $550.0K | |
| Net Income TTM | $-75M | $-78M | · | $-83M | $-81M | $-61M | · | $-51M | $-49M | $-65M | $-73M | $-74M | $-74M | $-72M | $-69M | $-65M | |
| Market Cap | $72M | $66M | · | $74M | $56M | $57M | · | $77M | $83M | $87M | $314M | $289M | · | $543M | $650M | $948M | |
| P/E | -1.0 | -0.8 | · | -0.9 | -0.7 | -0.9 | · | -1.5 | -1.7 | -1.3 | -3.9 | -3.9 | -2.9 | -7.5 | -9.4 | · | |
| P/S | 16.0 | 12.3 | · | 10.0 | 6.6 | 5.9 | · | 6.7 | 7.0 | 7.4 | 32.5 | 37.0 | · | 263.2 | 624.5 | 1723.6 | |
| P/B | 1.0 | 0.8 | · | 0.6 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | 1.3 | 1.3 | · | 2.1 | 2.3 | 3.2 | |
| P / Tangible Book | 1.0 | 0.8 | · | 0.6 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | 1.3 | 1.3 | · | 2.1 | 2.3 | 3.2 | |
| P / Cash Flow | · | -3.4 | · | · | · | -3.1 | · | · | · | -5.4 | · | · | · | · | · | -52.7 | |
| Earnings Yield | -105.2% | -119.3% | · | -114.3% | -148.1% | -108.3% | · | -66.4% | -59.3% | -77.6% | -25.4% | -25.9% | -34.0% | -13.4% | -10.7% | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı % | -1360.4% | -802.0% | -717.3% | -2124.1% | -12982.8% |
| Net Gelir | $-78M | $-59M | $-69M | $-73M | $-58M |
| Seyreltilmiş Hisse Başı Kâr | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 10.1 | 12.2 | 14.8 | 22.8 | 24.7 |
| Cari Oran | 9.9 | 11.8 | 14.5 | 22.3 | 24.3 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-74M | $-52M | $-57M | $-72M | $-48M |
Kurumsal Sahipler (13F) 69 dosya · $47.1M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
69
Tutulan Değer
$47.1M
Yeni pozisyonlar
5
Çıkan pozisyonlar
8
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 5 (-11 önceki Ç'ye göre) | 8 (0 önceki Ç'ye göre) | 15 (-2 önceki Ç'ye göre) | 22 (+4 önceki Ç'ye göre) | -2.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BML Capital Management, LLC | $7.142.200 | 5.330.000 | 15,18% | Hisse senetleri |
| TANG CAPITAL MANAGEMENT LLC | $5.688.414 | 4.245.085 | 12,09% | Hisse senetleri |
| Sio Capital Management, LLC | $3.529.744 | 2.634.137 | 7,50% | Hisse senetleri |
| Euclidean Capital LLC | $3.521.042 | 2.627.643 | 7,48% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3.162.400 | 2.360.000 | 6,72% | Hisse senetleri |
| VANGUARD GROUP INC | $2.712.888 | 2.170.310 | 5,77% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.696.107 | 2.012.020 | 5,73% | Hisse senetleri |
| ArrowMark Colorado Holdings LLC | $2.625.836 | 1.959.579 | 5,58% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $2.618.542 | 1.954.136 | 5,56% | Hisse senetleri |
| Eversept Partners, LP | $2.533.811 | 1.890.904 | 5,38% | Hisse senetleri |
| BlackRock, Inc. | $1.232.556 | 919.818 | 2,62% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $1.092.625 | 874.100 | 2,32% | Hisse senetleri |
| Stonepine Capital Management, LLC | $718.355 | 536.086 | 1,53% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $634.624 | 473.158 | 1,35% | Hisse senetleri |
| Aldebaran Capital, LLC | $626.359 | 467.432 | 1,33% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $574.663 | 428.853 | 1,22% | Hisse senetleri |
| BIT Capital GmbH | $546.124 | 407.555 | 1,16% | Hisse senetleri |
| Verdad Advisers, LP | $485.564 | 362.361 | 1,03% | Hisse senetleri |
| Walleye Capital LLC | $449.830 | 335.694 | 0,96% | Hisse senetleri |
| Assenagon Asset Management S.A. | $442.204 | 330.003 | 0,94% | Hisse senetleri |
| MARSHALL WACE, LLP | $430.956 | 321.610 | 0,92% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $341.399 | 254.775 | 0,73% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $321.747 | 240.110 | 0,68% | Hisse senetleri |
| CITADEL ADVISORS LLC | $271.082 | 202.300 | 0,58% | Alım opsiyonu |
| ADAR1 Capital Management, LLC | $269.351 | 201.008 | 0,57% | Hisse senetleri |
| STATE STREET CORP | $245.459 | 183.178 | 0,52% | Hisse senetleri |
| RBF Capital, LLC | $217.348 | 162.200 | 0,46% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $183.572 | 136.994 | 0,39% | Hisse senetleri |
| MAI Capital Management | $178.383 | 133.122 | 0,38% | Hisse senetleri |
| Rangeley Capital, LLC | $132.982 | 99.240 | 0,28% | Hisse senetleri |
| NORTHERN TRUST CORP | $124.683 | 93.047 | 0,26% | Hisse senetleri |
| Ikarian Capital, LLC | $119.442 | 89.136 | 0,25% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $94.475 | 70.504 | 0,20% | Hisse senetleri |
| PNC Financial Services Group, Inc. | $91.038 | 67.938 | 0,19% | Hisse senetleri |
| Quadrature Capital Ltd | $83.174 | 62.070 | 0,18% | Hisse senetleri |
| Seven Fleet Capital Management LP | $71.782 | 53.569 | 0,15% | Hisse senetleri |
| CITADEL ADVISORS LLC | $63.393 | 47.308 | 0,13% | Hisse senetleri |
| Accurate Wealth Management, LLC | $62.000 | 50.000 | 0,13% | Hisse senetleri |
| Cubist Systematic Strategies, LLC | $61.417 | 43.869 | 0,13% | Hisse senetleri |
| MORGAN STANLEY | $55.856 | 41.684 | 0,12% | Hisse senetleri |
| JANE STREET GROUP, LLC | $53.878 | 40.207 | 0,11% | Hisse senetleri |
| ALGERT GLOBAL LLC | $53.403 | 39.853 | 0,11% | Hisse senetleri |
| COOPER/HAIMS ADVISORS, LLC | $52.288 | 39.021 | 0,11% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50.292 | 37.531 | 0,11% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $43.496 | 32.460 | 0,09% | Hisse senetleri |
| Squarepoint Ops LLC | $42.656 | 31.833 | 0,09% | Hisse senetleri |
| HSBC HOLDINGS PLC | $40.776 | 30.891 | 0,09% | Hisse senetleri |
| BARCLAYS PLC | $37.201 | 27.761 | 0,08% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $36.349 | 27.126 | 0,08% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $28.889 | 21.559 | 0,06% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×5 başvurular | 04 Mart 2026 | 0,00% | Değişiklik | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 16 içeriden öğrenenler · 5 yöneticiler · 9 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Michael Carulli | Chief Financial Officer | 05 Mart 2026 A | 60.146 | 0 | 0 | $0 |
| Winston Kung | COO, CFO | 12 Mayıs 2023 A | 10.600 | 0 | 0 | $0 |
| Robert Ticktin | General Counsel & COO | 05 Mart 2026 A | 98.695 | 0 | 0 | $0 |
| Deepika Jalota | Chief Development Officer | 05 Mart 2026 A | 89.959 | 0 | 0 | $0 |
| Leila Alland | Chief Medical Officer | 15 Eylül 2023 S | 45.909 | 0 | 0 | $0 |
| Kirsten Flowers | Yönetim kurulu üyesi | 04 Haziran 2026 A | · | 0 | 0 | $0 |
| Laurie Stelzer | Yönetim kurulu üyesi | 04 Haziran 2026 A | · | 0 | 0 | $0 |
| Charles M Baum | Yönetim kurulu üyesi | 04 Haziran 2026 A | · | 0 | 0 | $0 |
| Carol Giltner Gallagher | Yönetim kurulu üyesi | 04 Haziran 2026 G | · | 0 | 0 | $0 |
| Arnold J Levine | Yönetim kurulu üyesi | 04 Haziran 2026 A | 409.842 | 0 | 0 | $0 |
| Richard A. Heyman | Yönetim kurulu üyesi | 05 Haziran 2025 A | 0 | 0 | 0 | $0 |
| Peter A. Thompson | Yönetim kurulu üyesi | 02 Haziran 2022 A | 475.000 | 0 | 0 | $0 |
| Thilo Schroeder | Yönetim kurulu üyesi | 06 Ekim 2021 S | 1.101.283 | 0 | 0 | $0 |
| Arnold L Oronsky | Yönetim kurulu üyesi | 29 Eylül 2020 C | 6.469.911 | 0 | 0 | $0 |
| David Henry Mack | · | 05 Mart 2026 A | 451.109 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | · | 29 Eylül 2020 C | 760.267 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 3 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
PMVP Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 12 analist
AL
Medyan hedef
$4.00
+123,5%
4 33,3%
Güçlü Al
7 58,3%
Al
1 8,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
5 analist · 2026-09-29Ortalama hedef $4.20 +134,6%
← Tüm hedeflerin altında
Mevcut fiyat $1.79
Düşük$3.00
Ortalama$4.20
Yüksek$5.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026